KFI
MRNA icon

Key Financial Inc’s Moderna MRNA Stock Holding History

Key Financial Inc’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.57K Hold
51
– – ﹤0.01% 1074
2026
Q1 		$2.59K Hold
51
– – ﹤0.01% 1141
2025
Q4 		$1.5K Hold
51
– – ﹤0.01% 1210
2025
Q3 		$1.41K Hold
51
– – ﹤0.01% 1234
2025
Q2 		$1.41K Hold
51
– – ﹤0.01% 1231
2025
Q1 		$1.45K Hold
51
– – ﹤0.01% 1183
2024
Q4 		$2.12K Sell
51
-375
-88% -$17.9K ﹤0.01% 1144
2024
Q3 		$28.5K Hold
426
– – 0.01% 578
2024
Q2 		$50.6K Hold
426
– – 0.01% 472
2024
Q1 		$45.4K Hold
426
– – 0.01% 450
2023
Q4 		$42.4K Sell
426
-250
-37% -$21K 0.01% 455
2023
Q3 		$69.8K Sell
676
-24
-3% -$2.68K 0.02% 348
2023
Q2 		$85K Sell
700
-1
-0.1% -$133 0.03% 326
2023
Q1 		$108K Buy
701
+176
+34% +$29K 0.04% 266
2022
Q4 		$62.1K Hold
525
– – 0.03% 324
2022
Q3 		$62K Buy
525
+375
+250% +$56.9K 0.03% 330
2022
Q2 		$22K Hold
150
– – 0.01% 489
2022
Q1 		$26K Hold
150
– – 0.01% 458
2021
Q4 		$38K Buy
+150
New +$43.9K 0.02% 383

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Key Financial Inc's MRNA Position: Q2 2026 in Review

Key Financial Inc held its Moderna (MRNA) position steady in Q2 2026 at 51 shares worth $3.57K. The position accounts for ﹤0.01% of the portfolio, ranked #1074.

Key Financial Inc first reported a position in MRNA in Q4 2021 and has held it in 19 quarters since. The position peaked at $108K in Q1 2023. 783 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Key Financial Inc held 51 shares of Moderna worth $3.57K as of Q2 2026.
  • Key Financial Inc left its Moderna share count unchanged in Q2 2026.
  • Moderna made up ﹤0.01% of Key Financial Inc's portfolio in Q2 2026, its #1074 holding.
  • Key Financial Inc first reported a position in Moderna in Q4 2021 and has held it in 19 quarters since.
  • Key Financial Inc's Moderna position peaked at $108K in Q1 2023.
  • 783 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Key Financial Inc's 13F filing for Q2 2026, filed 24 Jul 2026.